Page 41 - Ming Wang News Today : Breaking News, Live Updates & Top Stories | Vimarsana

socaltech.com San Diego-based Phanes Therapeutics, a developer of immuno-oncology drugs, has raised $40M in its Series B funding round. The funding was led by Sequoia Capital China, and also included the company other investors. Names of the other investors were not announced by the company. According to the company, the new funding will be used to advance several preclinical programs to clinic, expand the research and clinical teams, and support the advancement of research projects. Ming Wang, PhD/MBA is CEO of Phanes Therapeutics. The company said it is discovery and development of biologi...

/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative drug discovery in immuno-oncology, announced today the completion of $40...

Treat the COVID-19 pandemic now like the last leg of a race where the vaccine and new variants are competing. If the variants win, we are in trouble.

Critical Race Theory Weakens Society and Breeds Hate, Latinos Say Protesters carry signs during a demonstration against alleged police brutality in front of the Fraternal Order of Police offices in Columbus, Ohio, on Dec. 28.(Photo: Stephen Zenner/Agence France-Presse/Getty Images) Critical race theory, at one time limited primarily to academia, has become a controversial issue as it increasingly is showing up in K-12 school curriculums and in training in government agencies and corporate America. Speakers at a May 6 virtual event sponsored by Latinos for Tennessee, a traditional values ad...

Laboratory equipment. Photo: Pixabay May 7, 2021 Sequoia Capital China has led a $40-million Series B round for US-based biotech startup Phanes Therapeutics, while Turn Capital has acquired Taiwanese blockchain startup Dapp Pocket. Sequoia China leads $40m Series B round for biotech firm Phanes Phanes Therapeutics, a biotech startup with operations in the US and China, has secured $40 million in a Series B round of financing led by Sequoia Capital China, according to a statement on Thursday. Chinese private equity firm DYEE Capital; Volcanics Venture, an early-stage venture capital firm that ...